Filing Details

Accession Number:
0001127602-21-028140
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-02 16:59:12
Reporting Period:
2021-10-29
Accepted Time:
2021-11-02 16:59:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627985 Pat Beyer C/O Conmed Corporation
11311 Concept Boulevard
Largo FL 33773
President Int'l & Global Ortho No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-29 55,300 $39.87 63,107 No 4 M Direct
Common Stock Disposition 2021-10-29 30,018 $144.62 33,089 No 4 F Direct
Common Stock Disposition 2021-10-29 2,789 $144.50 30,300 No 4 S Direct
Common Stock Disposition 2021-10-29 16,904 $145.31 13,396 No 4 S Direct
Common Stock Disposition 2021-10-29 5,589 $146.14 7,807 No 4 S Direct
Common Stock Acquisiton 2021-10-29 50,700 $51.30 58,507 No 4 M Direct
Common Stock Disposition 2021-10-29 33,253 $146.28 25,254 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2021-10-29 55,300 $0.00 55,300 $39.87
Common Stock Sars (Stock Appreciation Rights) Disposition 2021-10-29 50,700 $0.00 50,700 $51.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-03-01 No 4 M Direct
0 2025-02-27 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  4. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  5. The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period.